Cargando…

Clinical Characteristics of Patients with Schizophrenia Maintained without Antipsychotics: A Cross-sectional Survey of a Case Series

OBJECTIVE: While antipsychotics are necessary for relapse prevention in the treatment of schizophrenia in general, some minority of patients may be maintained without continuous antipsychotic treatment. However, the characteristics of such patients are not well known and previous reports have not ev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tani, Hideaki, Tomita, Masayuki, Suzuki, Takefumi, Mimura, Masaru, Uchida, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553521/ https://www.ncbi.nlm.nih.gov/pubmed/34690131 http://dx.doi.org/10.9758/cpn.2021.19.4.773

Ejemplares similares

Drug Attitude, Insight, and Patient’s Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey
por: Nagai, Nobuhiro, et al.
Publicado: (2020)

Effectiveness of Saikokaryukotsuboreito (Herbal Medicine) for Antipsychotic-Induced Sexual Dysfunction in Male Patients with Schizophrenia: A Description of Two Cases
por: Takashi, Tsuboi, et al.
Publicado: (2014)

PM398. Fluctuations in hallucinatory experiences within a day in relation to dopamine D2 receptor blockade with antipsychotics in patients with schizophrenia
por: Koizumi, Teruki, et al.
Publicado: (2016)

Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross‐sectional study
por: Takahashi, Kie, et al.
Publicado: (2020)

Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey
por: Tani, Hideaki, et al.
Publicado: (2012)

Factor Structure of the Targeted Inventory on Problems in Schizophrenia
por: Tanaka, Shoji, et al.
Publicado: (2013)

PT567. Improvement to antipsychotic treatment at week 2 predicts subsequent treatment response in behavioral and psychological symptoms with dementia: Analysis of the CATIE-AD data
por: Yoshida, Kazunari, et al.
Publicado: (2016)

T166. VISUALIZATION OF AMPA RECEPTORS IN PATIENTS WITH SCHIZOPHRENIA AND DEPRESSION: THE FIRST PET IMAGING STUDY
por: Uchida, Hiroyuki, et al.
Publicado: (2020)

Dimensional distribution of cortical abnormality across antipsychotics treatment-resistant and responsive schizophrenia
por: Itahashi, Takashi, et al.
Publicado: (2021)

PS164. Concomitant Use of Benzodiazepine Hypnotics and Alcohol in Patients with Schizophrenia, Depression and Insomnia: A Preliminary Finding
por: Uchida, Takahito, et al.
Publicado: (2016)

Asymptomatic Deep Vein Thrombosis in a Patient with Major Depressive Disorder
por: Ishida, Takuto, et al.
Publicado: (2012)

Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
por: Tsujii, Takashi, et al.
Publicado: (2022)

Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry
por: Sakurai, Hitoshi, et al.
Publicado: (2022)

Satisfaction Survey on Antipsychotic Formulations by Schizophrenia Patients in Japan
por: Hatano, Masakazu, et al.
Publicado: (2021)

Magnetoencephalography Study of Right Parietal Lobe Dysfunction of the Evoked Mirror Neuron System in Antipsychotic-Free Schizophrenia
por: Kato, Yutaka, et al.
Publicado: (2011)

Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
por: Nomura, Kensuke, et al.
Publicado: (2021)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
por: Kamei, Hiroyuki
Publicado: (2022)

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2
por: Sajatovic, Martha, et al.
Publicado: (2018)

Reliability of the Glasgow Antipsychotic Side-effects Scale for Clozapine Japanese version (GASS-C-J)
por: Kitagawa, Kohei, et al.
Publicado: (2020)

Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response
por: Martins-de-Souza, Daniel, et al.
Publicado: (2015)

Positive Symptoms in Antipsychotic-naïve Schizophrenia are Associated with Increased Body Mass Index after Treatment
por: Lin, Shih-Hsien, et al.
Publicado: (2021)

Alteration in AMPA receptor subunit expression and receptor binding among patients with addictive disorders: A systematic review of human postmortem studies
por: Ueno, Fumihiko, et al.
Publicado: (2019)

Linked functional network abnormalities during intrinsic and extrinsic activity in schizophrenia as revealed by a data-fusion approach
por: Hashimoto, Ryu-ichiro, et al.
Publicado: (2017)

The Cumulative Effect of Antipsychotic Usage on Mortality in Schizophrenia: A Nationwide Population-based Cohort Study in Korea
por: Kim, Gyurin, et al.
Publicado: (2022)

Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study
por: Pae, Chi-Un, et al.
Publicado: (2020)

Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
por: Jeong, Seong Hoon, et al.
Publicado: (2018)

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns
por: Apiquian, Rogelio, et al.
Publicado: (2004)

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
por: Correll, Christoph U., et al.
Publicado: (2021)

PT594. Placebo effects in Alzheimer Disease: analysis of the CATIE-AD data
por: Ozawa, Chisa, et al.
Publicado: (2016)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia
por: Hemmati, Sahel, et al.
Publicado: (2010)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia
por: Aoki, Yumi, et al.
Publicado: (2023)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022)

Atypical antipsychotics are associated with incident diabetes in older adults without schizophrenia or bipolar disorder
Publicado: (2012)

Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis
por: Mizuno, Yuya, et al.
Publicado: (2019)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
por: Boiko, Anastasiia S., et al.
Publicado: (2021)

PM388. Brain function measures of therapeutic effects of pharmacotherapy in schizophrenia: An fMRI study
por: Hasegawa, Sayaka, et al.
Publicado: (2016)

Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey
por: Doane, Michael J, et al.
Publicado: (2020)

Cost of antipsychotic polypharmacy in the treatment of schizophrenia
por: Zhu, Baojin, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_jufeejttdj2kr40mn7u67gqgig